Back
Daktronics Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
45
DAKT
Daktronics
Last Price:
$16.03
Seasonality Move:
1.67%
Sell
41
SRPT
Sarepta Therapeutics
Last Price:
$107.93
Seasonality Move:
1.75%
Sell
45
Daktronics (DAKT)
is a Sell
Is Daktronics a Buy, Sell or Hold?
-
The current Daktronics [DAKT] share price is $16.07. The Score for DAKT is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
DAKT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $107.95. The Score for SRPT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DAKT Stock Price Chart
What is Daktronics's stock price today?
-
The Daktronics share price today is $16.07Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DAKT is experiencing slight buying pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $107.95Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
DAKT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.17 | Sell |
Relative Strength Index (14 RSI): | 44.62 | Sell |
Chaikin Money Flow: | 41864 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (16.11 - 16.97) | Sell |
Bollinger Bands (100): | (13.49 - 17.23) | Buy |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.94 | Sell |
Relative Strength Index (14 RSI): | 33.84 | Sell |
Chaikin Money Flow: | -502758 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (111.52 - 119.16) | Sell |
Bollinger Bands (100): | (114.38 - 127.78) | Sell |
DAKT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 16.23 | Sell |
20-day SMA: | 16.57 | Sell |
50-day SMA: | 16.98 | Sell |
200-day SMA: | 14.07 | Buy |
8-day EMA: | 16.2 | Sell |
20-day EMA: | 16.42 | Sell |
50-day EMA: | 16.34 | Sell |
200-day EMA: | 14.13 | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 111.57 | Sell |
20-day SMA: | 114.25 | Sell |
50-day SMA: | 119.8 | Sell |
200-day SMA: | 128.55 | Sell |
8-day EMA: | 110.88 | Sell |
20-day EMA: | 113.91 | Sell |
50-day EMA: | 117.81 | Sell |
200-day EMA: | 123.39 | Sell |
Daktronics Earnings Growth & DAKT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.15 per share, a decrease this year of $0.22 per share, and an increase next year of $0.12 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.70 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.63 per share, and an increase next year of $4.84 per share.
Daktronics Technical Analysis
Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |